Predicate |
Object |
contentType |
Journal Article|Research Support, Non-U.S. Gov't |
endingPage |
3 |
issn |
1465-542X 1465-5411 |
issueIdentifier |
4 |
pageRange |
162-3 |
publicationName |
Breast cancer research : BCR |
startingPage |
162 |
bibliographicCitation |
Gee JM, Giles MG, Nicholson RI. Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer. Breast Cancer Res. 2004;6(4):162–3. PMID: 15217488; PMCID: PMC468673. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_350a7ea0232a19d8072a72a96a29a4ba http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b298f5c0a20fc39533193ae747d4c534 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a1af013f2fc9c207588b61b55ced082 |
date |
2004-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/15217488 https://doi.org/10.1186/bcr904 https://pubmed.ncbi.nlm.nih.gov/PMC468673 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21884 https://portal.issn.org/resource/ISSN/1465-542X https://portal.issn.org/resource/ISSN/1465-5411 |
language |
English |
source |
https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer |
discusses |
http://id.nlm.nih.gov/mesh/M0216971 http://id.nlm.nih.gov/mesh/M0009659 http://id.nlm.nih.gov/mesh/M0280632 http://id.nlm.nih.gov/mesh/M0017888 http://id.nlm.nih.gov/mesh/M0178617 http://id.nlm.nih.gov/mesh/M0328038 http://id.nlm.nih.gov/mesh/M0328039 http://id.nlm.nih.gov/mesh/M0018586 http://id.nlm.nih.gov/mesh/M0024955 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_26e3b3a0ea8ee6116067a3b73abe7e5c http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 |